Pulsatile Drug Delivery Systems of Esomeprazole for Improved Therapeutic Efficiency: In-vivo Bioavailability Study and In-vitro In-vivo Correlation

Authors

  • Phaneendra Kurapati Department of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, Ananthapuram, Andhra Pradesh, India
  • Santhivardhan Chinni Raghavendra Institute of Pharmaceutical Education and Research, Ananthapuram, Andhra Pradesh, India

Abstract

The prime objective was development and pharmacokinetic characterization of pulsatile drug delivery systems (PDDS) to gain chronomodulated delivery of Esomeprazole (EMP) suitable for combating nocturnal acid breakthrough (NAB). Analytical method by HPLC was developed for the quantification of EMP from the biological samples. In vivo bioavailability testing was accomplished on Sprague–Dawley rats for the developed PDDS formulation. In-vitro in-vivo correlation (IVIVC) was carried out by deconvolution method. The bioanalytical approach that was developed exhibited linearity within the range of 100-2000ng/mL with correlation coefficient of 0.999. The results of other method validation parameters were found satisfactory. The in-vivo studies on the PDDS specified that the EMP was released as two pulses at the desired times. The AUC and MRT from the PDDS were found to be increased by 3.02 times and 2.2 times respectively in comparison with the marketed formulation. IVIVC revealed that considerably good correlation was observed. The established bioanalytical approach proved to be appropriate for quantifying EMP in biological samples. The developed PDDS formulation of EMP was effective to combat the NAB condition.

Keywords:

Pulsatile drug delivery systems, Nocturnal acid breakthrough, Esomeprazole, Bioavailability studies, In-vitro in-vivo correlation

DOI

https://doi.org/10.25004/IJPSDR.2024.160412

References

Tutuian R, Katz PO, Castell DO. Nocturnal acid breakthrough: pH, drugs and bugs. European Journal of Gastroenterology & Hepatology. 2004;16(5):441-443. Available from https://doi.org/10.1097/00042737-200405000-00001.

Tutuian R, Castell DO. Nocturnal acid breakthrough - approach to management. Medscape General Medicine. 2004;6(4):11. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1480544/

Karyampudi A, Ghoshal UC, Singh R, Verma A, Misra A, Saraswat VA. Esophageal acidification during nocturnal acid-breakthrough with ilaprazole versus omeprazole in gastroesophageal reflux disease. Journal of Neurogastroenterology and Motility. 2007;23(2):208-217. Available from https://doi.org/10.5056/jnm16087

Agarwal V, Bansal M. Statistical optimization and fabrication of a press coated pulsatile dosage form to treat nocturnal acid breakthrough. Current Drug Delivery. 2013;10(4):444-452. Available from https://doi.org/10.2174/1567201811310040009

Mogal RT, Galgatte UC, Chaudhari PD. Floating pulsatile drug delivery of Ranitidine Hydrochloride for nocturnal acid breakthrough: design, optimization, in-vitro and in-vivo evaluation. International Journal of Pharmacy and Pharmaceutical Sciences. 2013;5(3):722-727.

Brisebois S, Merati A, Giliberto JP. Proton pump inhibitors: Review of reported risks and controversies. Laryngoscope Investigative Otolaryngology. 2018;3(6):457-462. Available from https://doi.org/10.1002/lio2.187

Hua S. Advances in oral drug delivery for regional targeting in the gastrointestinal tract-influence of physiological, pathophysiological and pharmaceutical factors. Frontiers in Pharmacology. 2020;11:524. Available from https://doi.org/10.3389/fphar.2020.00524

Ciancia S, Cafarelli A, Zahoranova A, Menciassi A, Ricotti L. Pulsatile drug delivery system triggered by acoustic radiation force. Front Bioengineering and Biotechnology. 2020;8:317. Available from https://doi.org/10.3389/fbioe.2020.00317

Arora S, Ali J, Ahuja A, Baboota S, Qureshi J. Pulsatile drug delivery systems: An approach for controlled drug delivery. Indian Journal of Pharmaceutical Sciences. 2006;68(3):295-300. Available from https://doi.org/10.4103/0250-474X.26655

Jagdale SC, Suryawanshi VM, Pandya SV, Kuchekar BS, Chabukswar AR. Development of press-coated, floating-pulsatile drug delivery of lisinopril. Scientia Pharmaceutica. 2014;82:423–440. Available from https://doi.org/10.3797/scipharm.1301-27

Rashid R, Zaman M, Ahmad M, Khan MA, Butt MH, Salawi A, Almoshari Y, Alshamrani M, Sarfraz RM. Press-coated aceclofenac tablets for pulsatile drug delivery: Formulation and in vitro evaluations. Pharmaceuticals (Basel). 2022;15(3):326. Available from https://doi.org/10.3390/ph15030326

Kharwade R, Nair H, Masurkar D, Pise A, More S, Pise S. Formulation and evaluation of chronomodulated pulsatile drug delivery system for nocturnal hyperacidity. Research Journal of Pharmacy and Technology. 2022;15(4):1449-1454. Available from https://doi.org/10.52711/0974-360X.2022.00240

Srikar G, Shanthi D, Ramesh J, Kalyani V, Nagamma I. Floating microspheres: A prevailing trend in the development of gastroretentive drug delivery system. Asian Journal of Pharmaceutics. 2018;12(4):235-242. Available from https://doi.org/10.22377/ajp.v12i04.2831

Tekade AR, Gattani SG. Development and evaluation of pulsatile drug delivery system using novel polymer. Pharmaceutical Development and Technology. 2009;14(4):380-7. Available from https://doi.org/10.1080/10837450802712625

Kurapati P, Chinni S. Pulsatile drug delivery systems of esomeprazole: optimization through quality by design. Indian Journal of Pharmaceutical Education and Research. 2024;58(2):417-431. Available from https://doi.org/10.5530/ijper.58.2.47

Onal A, Oztunc A. Development and validation of high performance liquid chromatographic method for the determination of esomeprazole in tablets. Journal of Food and Drug Analysis. 2006;14(1):12-18. Available from https://doi.org/10.38212/2224-6614.2503

Krishna SR, Ramu A, Vidyadhara S, Rani AP. Bioavailability enhancement by floating microballoons of dipyridamole and clopidogrel: In vivo pharmacokinetic study. International Journal of Applied Pharmaceutics. 2021;13(6):216-220. Available from https://doi.org/10.22159/ijap.2021v13i6.42316

Kuril AK, Saravanan K. Method development and validation for the determination of higher molecular weight species of calcitonin salmon in calcitonin salmon injection by high-performance size exclusion chromatography. International Journal of Pharmaceutical Sciences and Drug Research. 2024;16(2):260-266. Available from https://doi.org/10.25004/IJPSDR.2024.160216

Le THH, Phung TH, Le DC. Development and validation of an HPLC method for simultaneous assay of potassium guaiacolsulfonate and sodium benzoate in pediatric oral powder. Journal of Analytical Methods in Chemistry. 2019;2019:6143061. Available from https://doi.org/10.1155/2019/6143061

Hasan S, Kumar N, Bakan JA. Microencapsulation. In: Khar RK, Vyas SP, Ahmad FJ, Jain GK, editors. The theory and practice of industrial pharmacy. Edn 3, CBS Publishers and Distributors, New Delhi, 2013, pp. 579-596.

Rai SY, Ravikumar P. Development and evaluation of microsphere based topical formulation using design of experiments. Indian Journal of Pharmaceutical Sciences. 2016;78(2):182-192. Available from https://doi.org/10.4172/pharmaceutical-sciences.1000102

Grandhi S, Rani AP, Pathuri R. Voriconazole solid lipid nanoparticles: Optimization of formulation and process parameters. Research Journal of Pharmacy and Technology. 2018;11(7):2829-2835. Available from https://doi.org/10.5958/0974-360X.2018.00522.X

Halder S, Shuma ML, Kabir AK, Rouf AS. In vitro release kinetics study of Esomeprazole Magnesium Trihydrate tablet available in Bangladesh and comparison with the originator brand (Nexium®). Stamford Journal of Pharmaceutical Sciences. 2011;4(1):79-83. Available from https://doi.org/10.3329/sjps.v4i1.8875

Dulla O, Sultana S, Shohag Hosen M. In vitro comparative quality evaluation of different brands of esomeprazole tablets available in selected community pharmacies in Dhaka, Bangladesh. BMC Research Notes. 2018;11(1):184. Available from https://doi.org/10.1186/s13104-018-3285-x

Kan SL, Lu J, Liu JP, Zhao Y. Preparation and in vitro/in vivo evaluation of esomeprazole magnesium-modified release pellets. Drug Delivery. 2016;23(3):866-873. Available from https://doi.org/10.3109/10717544.2014.919545

Zhang Y, Huo M, Zhou J, Xie S. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer Methods and Programs in Biomedicine. 2010;99(3):306-314. Available from https://doi.org/10.1016/j.cmpb.2010.01.007

Yuan J, Ma H, Cen N, Zhou A, Tao H. A pharmacokinetic study of diclofenac sodium in rats. Biomedical Reports. 2017;7(2):179-182. Available from https://doi.org/10.3892/br.2017.942

Lee DY, Shin S, Kim TH, Shin BS. Establishment of level a in vitro-in vivo correlation (IVIVC) via extended DoE-IVIVC model: A donepezil case study. Pharmaceutics. 2022;14(6):1226. Available from https://doi.org/10.3390/pharmaceutics14061226

CH S, Annapurna P, KS N. Analytical quality by design approach in RP-HPLC method development and validation for the estimation of duvelisib. Asian Journal of Pharmaceutical and Clinical Research. 2021;14(2):99-108. Available from https://doi.org/10.22159/ajpcr.2021.v14i2.40181

Srujani CH, Harika K, Nataraj KS, Pawar AK. RP-HPLC method development and validation for the determination of pemigatinib using design of experiments approach. Journal of Pharmaceutical Research International. 2020;32(40):26-48. Available from https://doi.org/10.9734/JPRI/2020/v32i4031031

Pavelkova MHJMKKVDSPM, Vyslouzil JMDVJ. Influence of emulsification mode, stirring speed and volume on ibuprofen-loaded PLGA microparticles. Ceska a Slovenska Farmacie. 2021;70(1):32-40. Available from https://pubmed.ncbi.nlm.nih.gov/34237951/

Cui C, Sun J, Wang X, Yu Z, Shi Y. Factors contributing to drug release from enteric-coated omeprazole capsules: An in vitro and in vivo pharmacokinetic study and IVIVC evaluation in beagle dogs. Dose Response. 2020;18(1):1559325820908980. Available from https://doi.org/10.1177/1559325820908980

Ghori MU, Grover LM, Asare-Addo K, Smith AM, Conway BR. Evaluating the swelling, erosion, and compaction properties of cellulose ethers. Pharmaceutical Development and Technology. 2018;23(2):183-197. Available from https://doi.org/10.1080/10837450.2017.1389958

Rokhade AP, Patil SA, Belhekar AA, Halligudi SB, Aminabhavi TM. Preparation and evaluation of cellulose acetate butyrate and poly (ethylene oxide) blend microspheres for gastroretentive floating delivery of repaglinide. Journal of Applied Polymer Science. 2007;105(5):2764-2771. Available from https://doi.org/10.1002/app.26456

Bhalani DV, Nutan B, Kumar A, Singh Chandel AK. Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines. 2022;10(9):2055. Available from https://doi.org/10.3390/biomedicines10092055

Liu H, Du K, Li D, Du Y, Xi J, Xu Y, Shen Y, Jiang T, Webster TJ. A high bioavailability and sustained-release nano-delivery system for nintedanib based on electrospray technology. International Journal of Nanomedicine. 2018;13:8379-8393. Available from https://doi.org/10.2147/IJN.S181002

Published

30-07-2024
Statistics
Abstract Display: 444
PDF Downloads: 441
Dimension Badge

How to Cite

“Pulsatile Drug Delivery Systems of Esomeprazole for Improved Therapeutic Efficiency: In-Vivo Bioavailability Study and In-Vitro In-Vivo Correlation”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 16, no. 4, July 2024, pp. 642-8, https://doi.org/10.25004/IJPSDR.2024.160412.

Issue

Section

Research Article

How to Cite

“Pulsatile Drug Delivery Systems of Esomeprazole for Improved Therapeutic Efficiency: In-Vivo Bioavailability Study and In-Vitro In-Vivo Correlation”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 16, no. 4, July 2024, pp. 642-8, https://doi.org/10.25004/IJPSDR.2024.160412.

Similar Articles

1-10 of 872

You may also start an advanced similarity search for this article.